Tong, Hannah
Thorne-Lyman, Andrew
Palmer, Amanda C.
Shaikh, Saijuddin
Ali, Hasmot
Gao, Ya
Pasqualino, Monica M.
Wu, Lee
Alland, Kelsey
Schulze, Kerry
West,, Keith P.
Hossain, Md Iqbal
Labrique, Alain B.
Article History
Received: 29 August 2023
Accepted: 17 February 2024
First Online: 27 February 2024
Declarations
:
: The protocol for the mCARE-II trial was reviewed and approved by institutional review board at the Bloomberg School of Public Health at Johns Hopkins University and Bangladesh Medical Research Council, Dhaka, Bangladesh (IRB No. 00006469, approved on August 27, 2015). The protocol for the JiVitA-6 trial was reviewed and approved by the institutional review board at the Bloomberg School of Public Health at Johns Hopkins University (IRB No. 00008000, approved on July 11, 2018) and the International Centre for Diarrhoeal Disease Research, Bangladesh (#PR-17119, approved on 21 April 2018).
: Not applicable.
: The authors declare that they have no competing interests.